In a bid to optimise the use of AI in drug development, US and European regulators have banded together to advise industry ...

FDA proposes framework clinical trial designs to guide Bayesian methods, improving efficiency in drug development for rare and pediatric conditions.

Researchers from the National Institutes of Health are using large language models to develop an artificial intelligence framework to streamline the clinical trial matching process and more quickly ...

Artificial intelligence (AI) is increasingly used to identify older adults for services, support people between visits, and ...

U.S. Food and Drug Administration (FDA) Commissioner Robert Califf, M.D., and other senior FDA officials recently published a “Special Communication” in JAMA describing FDA’s concerns with the use of ...

Please provide your email address to receive an email when new articles are posted on . ASN’s framework focuses on how AI can benefit patients by using clinical datasets. Data quality, bias and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Solicitation of clinician input during AI tool ...

Over the past few years, we’ve seen a wave of digital innovation in clinical trials: decentralized models, eConsent, real-time monitoring and direct-to-patient logistics. We’ve digitized nearly every ...

Since 2021, Korean researchers have been providing a simple software development framework to users with relatively limited ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...